Form4insider filings, from the source

SEC Form 4 · accession 0000921895-16-003967

Enveric Biosciences, Inc. · ENVB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jeffrey E. Eberwein
Director · 10% Owner
Period of report
Mar 31, 2016
Accepted (ET)
Apr 4, 2016 · 7:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F4Mar 31, 2016P41$6.51A40,242IBy: Separately Managed Account
Common StockF1,F4Apr 4, 2016P44$6.45A40,286IBy: Separately Managed Account
Common StockF1,F2holding———555,644IBy: Lone Star Value Investors, LP

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses